Your Location:Home >Products >API >90357-06-5

pd_meltingpoint:191-193 °C
Appearance:off-white crystalline solid
Purity:99%
Cosmetics Grade Bicalutamide 90357-06-5 For Sale with Good Price We supply high quality Bicalutamide (CAS 90357-06-5), in stock, factory directly supply to clients, lower prices, more competitiveness.
Bicalutamide is off-white crystalline solid, while it's Molecular Formula is C18H14F4N2O4S. Bicalutamide (CDX) has been used as an androgen receptor (AR) antagonist in prostate, bladder cancer cell lines and human fetal skeletal muscle cells. It has also been used as a supplement in RPMI 1640 for culturing androgen-independent LNCaP (LNCaP-AI) cell line.
The CAS number of Bicalutamide is 90357-06-5.
More information of Bicalutamide 90357-06-5 are:
|
Synonyms |
(2S)-N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methyl-propanamide;Casodex;Propanamide, N-(4-cyano-3-(trifluoromethyl)phenyl)-3-((4-fluorophenyl)sulfonyl)-2-hydroxy-2-methyl-, (+-)-;Bicalutamide (JAN/USP);Casodex (TN);(±)-N-[4-cyano-3-(trifluoromethyl)phenyl]-3-methyl-[(4- fluorophenyl) sulfonyl]-2-hydroxy- 2-methyl propanamide;N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-fluorophenylsulfonyl)-2-hydroxy-2-methylpropanamide;Bicalutamide [USAN:BAN:INN];ICI 176334;Propanamide,N-[4-cyano-3-(trifluoromethyl)- phenyl]-3-[(4-fluorophenyl)sulfonyl]-2- hydroxy-2-methyl-; |
|
CAS Number |
90357-06-5 |
|
Molecular Formula |
C18H14F4N2O4S |
|
Molecular Weight |
430.38 |
|
Density |
1.52 g/cm3 |
|
Melting Point |
191-193 °C |
|
Boiling Point |
650.3 °C at 760 mmHg |
|
Flash Point |
347.1 °C |
|
HS CODE |
29242995 |
|
PSA |
115.64000 |
|
LogP |
4.03338 |
|
Pka |
11.49±0.29(Predicted) |
Bicalutamide was launched in the United Kingdom, its first worldwide market, for the treatment of advanced prostate cancer in combination with an LHRH analog or surgical castration. A non-steroidal, peripherally selective antiandrogen, bicalutamide inhibits the action of dihydrotestosterone and testosterone at target sites by competitive binding to the cytosolic androgen receptor. It was reportedly well tolerated with no significant cardiovascular and metabolic side effects due to the benefit of lacking any steroid activity. The efficacy of bicalutamide as a monotherapy has been demonstrated clinically. Promising response rates were also reported in treating colorectal, breast, pancreas and non-small cell lung cancers.
InChI:InChI=1/C18H14F4N2O4S/c1-17(26,10-29(27,28)14-6-3-12(19)4-7-14)16(25)24-13-5-2-11(9-23)15(8-13)18(20,21)22/h2-8,26H,10H2,1H3,(H,24,25)/t17-/m1/s1
Articles related to Bicalutamide:
|
Article |
Source |
|
Preparation method of (R)-bicalutamide intermediate |
- Paragraph 0068-0070, (2021/04/21) |
|
Preparation of a novel bridged bis(β-cyclodextrin) chiral stationary phase by thiol-ene click chemistry for enhanced enantioseparation in HPLC |
Gong, Bolin,Guo, Siyu,Zhang, Ning , p. 35754 - 35764 (2021/12/02) |
Zibo Yurui Biotechnology Co., Ltd is a quality supplier and manufacturer of Bicalutamide . You can buy high quality, low price Bicalutamide 90357-06-5 here. Contact us.
CAS:2212020-52-3
CAS:154361-50-9
CAS:16004-75-4
CAS:150399-23-8